Search

Your search keyword '"Hamelmann Eckard"' showing total 988 results

Search Constraints

Start Over You searched for: Author "Hamelmann Eckard" Remove constraint Author: "Hamelmann Eckard"
988 results on '"Hamelmann Eckard"'

Search Results

3. Primary Prevention of Allergic Diseases: Current Concepts and Mechanisms

4. Perceptions of the impact of individual allergic rhinitis symptoms: A survey of ARIA clinical experts

5. Efficacy and safety of gene therapy with onasemnogene abeparvovec in children with spinal muscular atrophy in the D-A-CH-region: a population-based observational study

8. Research needs in allergy: an EAACI position paper, in collaboration with EFA

9. Impaired resolution of inflammatory response in the lungs of JF1/Msf mice following carbon nanoparticle instillation

10. Pathway focused protein profiling indicates differential function for IL-1B, -18 and VEGF during initiation and resolution of lung inflammation evoked by carbon nanoparticle exposure in mice

18. The German National Pandemic Cohort Network (NAPKON): rationale, study design and baseline characteristics

20. German asthma net: Nasal polyposis in patients in the severe asthma registry.

21. Allergische Krankheiten

23. White paper on peanut allergy – part 1: Epidemiology, burden of disease, health economic aspects

24. Recommendations for asthma monitoring in children:A PeARL document endorsed by APAPARI, EAACI, INTERASMA, REG, and WAO

25. Impact of Lung Function on Asthma Exacerbation Rates in Children Treated with Dupilumab: The VOYAGE Study

26. Practical handling of allergic reactions to COVID-19 vaccines: A position paper from German and Austrian Allergy Societies AeDA, DGAKI, GPA and ÖGAI

27. Ingestion of several rubber gloves: A case report on Pica syndrome.

28. Impact of COVID-19 on Pediatric Asthma: Practice Adjustments and Disease Burden

29. Development of the Microbiota and Associations With Birth Mode, Diet, and Atopic Disorders in a Longitudinal Analysis of Stool Samples, Collected From Infancy Through Early Childhood

32. As-needed low-dose inhaled corticosteroid/formoterol therapy in patients with severe asthma included in the German Asthma Net cohort

33. Impact of Lung Function on Asthma Exacerbation Rates in Children Treated with Dupilumab: The VOYAGE Study

34. Improved Lung Function is Associated With Better Asthma Control in Children Aged 6 to 11 Years With Moderate-To-Severe Type 2 Asthma: A Post Hoc Analysis of VOYAGE

35. Severe allergic reactions after COVID-19 vaccination with the Pfizer/BioNTech vaccine in Great Britain and USA: Position statement of the German Allergy Societies: Medical Association of German Allergologists (AeDA), German Society for Allergology and Clinical Immunology (DGAKI) and Society for Pediatric Allergology and Environmental Medicine (GPA)

39. Pimecrolimus in atopic dermatitis: Consensus on safety and the need to allow use in infants

42. An integrated molecular risk score early in life for subsequent childhood asthma risk.

43. Quantifying the benefits of early sublingual allergen immunotherapy tablet initiation in children.

45. DUPILUMAB REDUCES RESCUE SYSTEMIC CORTICOSTEROID USE IN CHILDREN WITH UNCONTROLLED MODERATE TO SEVERE ASTHMA REGARDLESS OF PRIOR EXACERBATION HISTORY

49. Correction to “ARIA guideline 2019: treatment of allergic rhinitis in the German health system”

Catalog

Books, media, physical & digital resources